Home
Richard A. Heyman, Director: Enliven Therapeutics ELVN Sell · Filed 23/12/21
Trade details
- Type
- Insider sale
- Amount
- $27,472.2
- Shares · price
- 2,110 sh · $13.02 a share
- Held after
- 147,455 sh
- Trade date
- 23/12/20
- Filed
- 23/12/21
- Days to filing
- 1 days
Sold 1.4% of holdings
- Share of holding sold
- 1.4%
Enliven Therapeutics trades, last 26 weeks
What else happened in Enliven Therapeutics around then
Filed or reported within 30 days of the trade day · 23/11/20~24/01/19Richard A. Heyman's recent trades
- Richard A. Heyman
Planned saleEnliven Therapeutics
Planned saleEnliven Therapeutics
ELVN
$2.3M
38,000 sh
$2.3M
Filed 09/04
Traded 09/04
- Richard A. Heyman
Planned sale10b5-1 planOric Pharmaceuticals
Planned sale10b5-1 planOric Pharmaceuticals
ORIC
$84K
7,000 sh
$84K
Filed 07/06
Traded 07/06
- Richard A. Heyman
Planned sale10b5-1 planOric Pharmaceuticals
Planned sale10b5-1 planOric Pharmaceuticals
ORIC
$76.8K
6,400 sh
$76.8K
Filed 07/06
Traded 07/06
- Richard A. Heyman
Sell10b5-1 planEnliven Therapeutics
Sell10b5-1 planEnliven Therapeutics
ELVN
$32.2K
1,230 sh
$32.2K
Filed 02/19
Traded 02/17
- Richard A. Heyman
Planned sale10b5-1 planEnliven Therapeutics
Planned sale10b5-1 planEnliven Therapeutics
ELVN
$32.9K
1,230 sh
$32.9K
Filed 02/17
Traded 02/17
